<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Summers, Jaye</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kim, Yong Sang</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Mesenchymal Stem Cell Injection as a Treatment Adjunct in Patients With OLT</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-05-01 11:17:10</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">5-6</style></pages><abstract><style  face="normal" font="default" size="100%">Osteochondral lesions of the talus can be repaired using bone marrow stimulation. However, clinical outcomes may be less than desirable in older patients or those with very large defects. Direct injection of mesenchymal stem cells as an adjunct to bone marrow stimulation may offer a reasonable alternative for these patients.</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>